Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE213.55-5.85 (-2.67 %)
PREV CLOSE ( ) 219.40
OPEN PRICE ( ) 221.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21199
TODAY'S LOW / HIGH ( )205.25 221.20
52 WK LOW / HIGH ( )85.5 283
NSE213.60-6.1 (-2.78 %)
PREV CLOSE( ) 219.70
OPEN PRICE ( ) 217.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 213.60 (460)
VOLUME 109616
TODAY'S LOW / HIGH( ) 206.00 224.00
52 WK LOW / HIGH ( )85.05 283.45
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-30018000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

30Jul Lincoln Pharmaceuticals launches Vitam
With a commitment towards ‘Healthcare For All’, Lincoln Pharmaceuticals..
30Jul Lincoln Pharmaceuticals surges on laun
Lincoln Pharmaceuticals is currently trading at Rs. 198.60, up by 2.85 p..
19May Lincoln Pharmaceuticals gets European
Lincoln Pharmaceuticals has received the European Union (EU) GMP certifi..
19May Lincoln Pharmaceuticals soars on getti
Lincoln Pharmaceuticals is currently trading at Rs. 165.00, up by 1.15 p..
27Apr Lincoln Pharmaceuticals gets nod to ma
Lincoln Pharmaceuticals has received approval to manufacture Hydroxychlo..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit149.89495.63
Gross Profit 206.72 640.46
Operating Profit 224.15714.99
Net Sales 1010.333760.88

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  8497.85 (1.71%)
M.Cap ( in Cr)19571.08
Ipca Laboratories (BSE)
peergroup  2153.70 (3.77%)
M.Cap ( in Cr)27320.14
Pfizer (BSE)
peergroup  5062.10 (0.98%)
M.Cap ( in Cr)23157.96
NGL Fine-Chem (BSE)
peergroup  874.45 (4.99%)
M.Cap ( in Cr)540.24
Ajanta Pharma (BSE)
peergroup  1634.75 (1.90%)
M.Cap ( in Cr)14265.04

Shareholding Pattern

NON-INSTITUTION 67.59%
PROMOTERS 32.41%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 213.55. Its current market capitalisation stands at Rs 427.1 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3995.73 Cr and Total Income of Rs.3975.31 Cr. The company's management includes Hashmukhbhai Patel, Saurin J Parikh, Meha Patel, Pirabhai Suthar, Ishwarlal Patel, Arvind G Patel, Rajnikant G Patel, Ashish Patel, Munjal M Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are ACC Ltd. It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)